The importance of surgical therapy with expansion of TAVR to low-risk patients
| Autor: | Garrett Brown, Donald L. Quimby, Erol V. Belli, Bibhu D. Mohanty |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Pulmonary and Respiratory Medicine
Reoperation medicine.medical_specialty medicine.medical_treatment Heart Valve Diseases Disease 030204 cardiovascular system & hematology Prosthesis Design Transcatheter Aortic Valve Replacement 03 medical and health sciences 0302 clinical medicine Valve replacement Bicuspid valve medicine.artery Ascending aorta medicine Humans Intensive care medicine Heart Valve Prosthesis Implantation business.industry Gold standard valvular heart disease Standard of Care medicine.disease Cardiac surgery 030228 respiratory system Coronary occlusion Heart Valve Prosthesis cardiovascular system Surgery Cardiology and Cardiovascular Medicine business |
| Zdroj: | Journal of cardiac surgeryREFERENCES. 34(12) |
| ISSN: | 1540-8191 |
| Popis: | Despite the landmark release of recent transcatheter aortic valve replacement data, the gold standard of surgical therapy is here to stay. Surgery remains vital in patient populations with low coronary height raising risk of coronary occlusion, aneurysmal ascending aorta, isolated aortic regurgitation, noncalcific disease, bicuspid valves, and multivessel coronary disease, or other structural abnormality requiring cardiac surgery. Consideration of these issues highlights the ongoing importance of multidisciplinary consideration of individual patient cases, careful review of imaging, and preservation of a robust surgical program to complement transcatheter development. As the landscape of valvular heart disease management continues to evolve, the surgeon's role is changing, but by no means diminished and their engagement in heart team decision making remains paramount. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |